Dolutegravir Sodium

6 trials 3 recruiting JAnti-infectives

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

3 Completed trials

5 Sponsors

7 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 3 Phase IV: 2

Indications tested

HIV infection 2

Sponsors using this IMP

Inserm 2 Chelsea And Westminster Hospital NHS Foundation Trust 1 Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal 1 Fundacion Seimc Gesida 1 Radboud universitair medisch centrum Stichting 1

All trials

6 total

Interventional, multicenter, open-label, randomized, non-comparative trial evaluating the safety, in terms of HBV virological control, of 2 … Recruiting

2023-508634-34-00 Phase II 1 country Inserm
Phase II, multicenter, open-label, randomized, controlled, open-label clinical trial to eliminate the latent reservoir of HIV-1 by administr… Recruiting

2024-513366-18-00 Phase II 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Caj…
ANRS0392s ELDORADO : Phase III, open-label, randomized, multicenter trial EvaLuating the non-inferiority of DORAvirine versus DOlutegravir b… Recruiting

2023-508626-10-00 Phase III 1 country Inserm
Efficacy of doravirine + dolutegravir dual therapy in the context of antiretroviral therapy switch Ended

2023-509751-14-03 Phase II 1 country Chelsea And Westminster Hospital NHS Foundation Trust
Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment… Ended

2022-503110-23-00 Phase IV 1 country Fundacion Seimc Gesida
Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Ended

2024-515487-31-00 Phase IV 5 countries Stichting Radboud universitair medisch centrum

Showing 1–6 of 6 trials

← All drugs A–Z